NCT04323137View on ClinicalTrials.gov

Encouraging Flu Vaccination Among High-Risk Patients Identified by ML

NACompletedINTERVENTIONAL
Enrollment

117,649

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

September 21, 2021

Conditions
InfluenzaVaccinationHealth PromotionHealth BehaviorRisk Reduction
Interventions
BEHAVIORAL

Risk reduction

Mailed letter, SMS, and/or patient portal message

BEHAVIORAL

Medical records-based recommendation

Mailed letter, SMS, and/or patient portal message

BEHAVIORAL

Algorithm-based recommendation

Mailed letter, SMS, and/or patient portal message

Trial Locations (1)

17822

Geisinger, Danville

Sponsors

Lead Sponsor

Geisinger Clinic
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Geisinger Clinic

OTHER

NCT04323137 - Encouraging Flu Vaccination Among High-Risk Patients Identified by ML | Biotech Hunter | Biotech Hunter